|
Volumn 2, Issue 4, 2010, Pages 333-335
|
All people over 75 years with a five-year CVD risk of ≥15% should be treated with statins unless specifically contraindicated
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
AGED;
CARDIOVASCULAR DISEASE;
CLINICAL PRACTICE;
DRUG CONTRAINDICATION;
FEMALE;
HUMAN;
MALE;
NOTE;
RISK ASSESSMENT;
AGED;
AGED, 80 AND OVER;
CARDIOVASCULAR DISEASES;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
PHYSICIAN'S PRACTICE PATTERNS;
RISK ASSESSMENT;
|
EID: 79952277280
PISSN: 11726164
EISSN: 11726156
Source Type: Journal
DOI: 10.1071/hc10333 Document Type: Article |
Times cited : (2)
|
References (7)
|